10.1056/NEJMra1510062 62 WoottenD.ChristopoulosA.Marti-SolanoM.BabuM
from spring to autumn, the patient is injected under the skin with an implant (16mg) every two months
These include MYD88, C-C motif chemokine ligand 2 (CCL2/MCP1), IFN-, Spi-1 proto-oncogene (SPI1/PU.1), TNF-, inhibitor of nuclear factor kappa-B kinase subunit epsilon (IKBKE/IKK-i), SOCS1, miR-let-7, INPP5D, IL-1, and others
Powders dissolved in water sidestep this problem entirely they absorb without the mechanical burden of a solid tablet in a slowed digestive system
Simply wait until your next regularly scheduled day and resume your treatment as normal, ensuring you consult your healthcare provider if you have concerns about the gap in treatment